Evaluation of non-ATP competitive PI3K? inhibition with IOA-244 in the treatment of lymphoma

• Unité de recherche: INNOSUISSE
• Numéro de projet: 55179.1 IP-LS
• Titre du projet anglais: Evaluation of non-ATP competitive PI3K? inhibition with IOA-244 in the treatment of lymphoma

Mots-clé (Anglais)

Life sciences, Pharmaceuticals

Résumé des résultats (Abstract) (Anglais)

Inhibition of PI3K? is an established modality for the treatment of lymphoma. The proposed project will deliver mechanistic and efficacy information on iOnctura?s PI3K? inhibitor IOA-244, which has a novel mechanism of target inhibition.